A trial comparing surgery with ablation treatment for people with bowel cancer spread to the liver (LAVA)

Cancer type:

Bowel (colorectal) cancer
Cancer spread to the liver
Colon cancer
Rectal cancer
Secondary cancers

Status:

Results

Phase:

Pilot

This trial was for people with secondary cancer Open a glossary item in the liver that could be removed with surgery or a treatment using heat to kill the cancer cells. 

The heat treatment is called thermal ablation and includes radiofrequency ablation (RFA) Open a glossary item or microwave ablation Open a glossary item treatment.

More about this trial

Sometimes cells can break away from where the cancer first started and spread to other parts of the body, such as the liver. This is called metastatic or secondary liver cancer. 

When this trial was done, one of of the usual treatments was to remove these areas with an operation. This was standard treatment for advanced bowel cancer if you are under 70 years old and fit enough for an operation. 

Removing liver tumours is major surgery. And doctors aren’t sure of the best treatment for people where having surgery could be risky. For example in:

  • older people
  • people with other medical conditions such as heart or lung problems
  • people who have large areas of cancer in the liver

Researchers thought treatment to kill cancer cells with heat might help. This is called thermal ablation. It was already used to treat advanced bowel cancer in the liver when this trial was done. 

In this trial, doctors wanted to find out for sure which treatment works best for the above groups of people. 

The main aims of the trial were to:

  • find out how willing people are to take part
  • find out if thermal ablation or surgery works best
  • learn more about side effects and how they affect quality of life Open a glossary item

Summary of results

This trial closed early so there won't be any results available. 

Recruitment start:

Recruitment end:

How to join a clinical trial

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Chief Investigator

Professor Brian Davidson

Supported by

National Institute for Health Research (NIHR)
University College London (UCL)
University of Leeds

If you have questions about the trial please contact our cancer information nurses

Freephone 0808 800 4040

Last review date

CRUK internal database number:

14105

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Last reviewed:

Rate this page:

No votes yet
Thank you!
We've recently made some changes to the site, tell us what you think